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Abstract—Colorimetric, chemiluminescence and refractive 
index based diagnostics are some of the most important sensing 
techniques in biomedical science and clinical medicine. 
Conventionally laboratories and medical clinics rely on bulky 
and dedicated equipment for each diagnostic technique 
independently.  In this paper, we present CMOS sensor based 
solutions, comprising a single photon avalanche detector array 
and photodiode array. The CMOS platform offers low cost 
integration and wide range of light-based diagnostic techniques, 
leading to development of point-of-care devices. 
Keywords—SPAD, photodiode, colorimetric, 
chemiluminescence, refractive index,  CMOS. 
I.  INTRODUCTION  
Light-based sensing techniques such as colorimetric, 
chemiluminescence and refractive index change are well 
established for diagnosing diseases in laboratories and health 
care centers. The spectrophotometer colorimetric technique, 
for instance, is used in blood test for biomarker detection, 
while chemiluminescence is used for more sensitive assays 
requiring detection of low concentration biomarkers. 
Meanwhile, refractive index sensor can be used for label-free 
protein-protein or protein-antigen assessment. Each of these 
techniques require a dedicated instrument that is usually bulky 
and power hungry due to their discrete component 
configuration [1]–[4]. A general purpose spectrophotometer 
that is used for colorimetric assays usually incorporates a 
sophisticated setup comprising a white light source, 
monochromator containing a diffraction grating and a light 
transducer which converts light into electrical signal [5], [6]. 
Similarly, chemiluminescence requires an ultra-sensitive light 
detector such as a photomultiplier tube or charge coupled 
device (CCD) to sense the weak luminescence from low 
concentration biomarkers [2].  
Complementary metal oxide semiconductor (CMOS) 
technology has revolutionised the microelectronics industry 
and made a huge impact on telecommunications and bio-
sensing technologies. In this paper, we demonstrate the 
implementation of the aforementioned techniques using a 
commercially available CMOS process. For colorimetric and 
refractive index sensing we have used a CMOS based 
photodiode (PD) array while for the more sensitive detection 
such as chemiluminescence, we have used the CMOS based 
single photon avalanche detector (SPAD). Adopting CMOS 
technology as a platform for optically based diagnostic opens 
the possibility for integration of different bio-sensing 
techniques and microelectronics. Furthermore, it offers a low 
cost solution that can be mass-manufactured for use in point-
of-care devices [7]. 
The remainder of this paper is organised as follows. In 
section II, a description of the PD CMOS chip and the SPAD 
CMOS chip is presented. This is followed in section III by a 
description of the implementation and practical evolution of 
colorimetric, chemiluminescence and refractive index sensing 
techniques using our designed CMOS chips.  
 
II. INTEGRATED CHIPS DESIGN 
The PD is a p-n junction-based photosensitive detector. 
CMOS imagers are typically formed from an array of active 
pixel sensors (APS) each incorporating a PD and 3 transistors 
enabling data readout [8]. The PD layer structure is shown in 
Fig.1.a, while Fig.1.b shows the readout circuit of the PD. The 
incident photons on the device’s active area are absorbed by 
the PD, which generates a photocurrent Iph, leading to a 
change of the voltage across the diode as the device 
capacitance is discharged. This voltage is connected to Vout 
when Vsel is set to Vdd. The amplitude of Vout is inversely 
proportional to the intensity of the detected light. 
 
 
 
Fig. 1. a) Cross section of a rectangular shaped PD. b) Circuit diagram of 
a PD pixel. c) Cross section of a circular shaped SPAD.  d) Circuit diagram of 
a SPAD readout. Both detectors were fabricated in a CMOS process.  
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Fig. 2. a) Photograph of the 3.4 mm × 3.6 mm PD array chip. b) Packaged 
PD chip with epoxy and protection for wet biochemistry.  c) Photograph of the 
3.7 mm × 3.7 mm SPAD array chip.   d) Packaged SPAD chip. 
 
The SPAD is a pn-junction similar in structure to PD. 
However, unlike the PD, the SPAD is reverse-biased above its 
breakdown voltage to operate in Geiger mode. In order to 
withstand the high bias voltage, the SPAD is designed using a 
circular shaped layout with suitable implant spacing that 
allows for avalanche multiplication to take place (see Fig. 1.c) 
[8]. At such high bias voltage, an electric field within the 
active region of the junction is created. When a photon 
impacts on the active area, the SPAD initiates an avalanche 
process creating a large current pulse to be readily detected by 
a controlled threshold comparator (M2/M3). An n-channel 
MOSFET M1 (Fig.1.d) is used to quench the avalanche current 
and thus making the device ready for the next photon to be 
detected [9]. The width of the pulse is determined by the bias 
voltage Vq which sets the discharging time of the SPAD 
terminal capacitance. The faster the discharge time, the lower 
the unwanted after pulsing and higher the detection dynamic 
range. The pulses rate generated by the SPAD are proportional 
to the number of the photons detected. An array of 32 bit 
digital counters is integrated on the chip to count the pulses at 
a given exposure time. 
 In order to demonstrate the capability of the two CMOS 
based detectors, we designed and fabricated two chips using 
commercially available CMOS processes. One chip was 
incorporated a 16×16 PDs array imager along with readout and 
control circuits. The PD chip (Fig. 2.a) was fabricated using a 
Taiwan Semiconductor Manufacturing Company (TSMC) 
180 nm process. The second chip incorporated a 32×32 array 
of SPADs along with readout, pulse counting, addressing and 
control circuits. It also incorporated a variable high voltage (3-
37.9 V) charge pump for reverse biasing the SPADs at 22V 
from a 3.3V supply. The chip (Fig. 2.c) was fabricated using 
Austriamicrosystems’ (AMS) 350 nm high voltage process. 
The photodiode chip exhibited a maximum photo response at c. 
600 nm whereas, the SPAD chip exhibited a maximum photon 
detection probability at c. 475 nm. Both chips were wire 
bonded and packaged using epoxy for wet biochemistry (Fig. 
2.b and 2.d). 
 
Fig. 3. A schematic illustration of the experimental mechanism of 
colorimetric sensing. During reaction the solution changes colour, resulting in 
fewer photons from the LED reaching the photodiode, changing the reading of 
the PD which indicates the cholesterol level. 
 
Fig. 4. Experimental results of colorimetric experiments using PD. The 
measurements show different cholesterol concentrations. The voltage response 
of the PD increases proportionally to the change in cholesterol concentration.   
 
III. OPTICAL DIAGNOSTIC MODALITIES 
In this section, biological or bio-chemical experiments are 
conducted to validate the use of the PD array and the SPAD 
array for colorimetric, chemiluminescence and refractive 
index sensing. 
 
A. Colorimetric sensing 
For colorimetric measurements, an experiment was designed 
to quantify cholesterol concentration in human blood serum by 
means of colour changes. In this experiment, the PD was used 
in conjunction with an off-the-shelf green LED light source 
and a CMOS PD array, as illustrated in Fig. 3. In order to 
quantify cholesterol levels in human serum, a triple enzyme 
assay was devised comprising two cholesterol reactions 
(cholesterol esterase and cholesterol oxidase), together with an 
oxidation step of o-Dianisidine to produce a coloured product 
that changes monotonically to deep orange colour via 
horseradish peroxidase. The coloured product is indirectly 
proportional to cholesterol concentration. By evaluating the 
colour intensity of o-Dianisidine that has an adsorption peak at  
 
 
Fig. 5. A schematic illustration of the experimental mechanism of the 
chemiluminescence detection. The photon emission of the peroxidase 
conjugated antibodies reaction is detected by the SPAD. 
 
 
 
 
Fig. 6. Varying concentrations of hydrogen peroxide with luminol during 
a chemiluminescent assay are detected by the SPAD.  
 
c. 460 nm and the PD responsivity that has a maximum peak 
at c. 600 nm. Therefore, the green LED was selected as a light 
source, with a wavelength peak around 500 nm to match the 
coincidence of the o-Dianisidine spectrum and PD spectrum. 
In this experiment, we have used varying dilutions of 
human serum to produce correspondingly varying 
concentrations of cholesterol, with a fixed enzyme 
concentration. The measurement was carried out by first 
pretreating the serum with cholesterol esterase to release all 
cholesterol esters to free cholesterol, followed by transferring 
the cholesterol oxidase and peroxidase reactions on top of the 
PD array. Fig. 4 shows that the PD array is capable of 
resolving varying cholesterol concentrations, showing a 
corresponding variation in final plateau voltage. No change in 
voltage was observed when cholesterol was omitted to show 
that the enzyme assay is substrate specific. The lowest 
cholesterol concentration measured was 29 μM with a limit of 
detection of 13 μM, which is 400 times lower than 
physiological range, proving that it can be used for greater 
sensitivity applications. 
 
B. Chemiluminescence sensing 
As discussed previously, the SPAD was chosen for 
conducting chemiluminescence sensing. A proof of concept 
experiment was designed (see Fig. 5) to detect the 
concentration of peroxidase conjugated antibodies, which emit 
blue light when mixed with luminol and hydrogen peroxide. 
This results in a blue light emission within the visible 
detection range of silicon-based detectors. The data presented 
in Fig. 6 shows the variation in signal as the concentration of 
hydrogen peroxide is altered from 0.15 % to 0.3 %. It is clear 
that the higher concentrations of hydrogen peroxide produce 
more photons, which is readily detected by the SPAD array. 
We used this chemilunescence technique to validate the SPAD 
and we foresee future measurements involving immunoassays 
such as HIV and troponin detection [9].  
The assay for chemilunescence detection was prepared as 
follows: First, 0.8 g potassium hydroxide was dissolved in 
20 ml of purified water. Then 0.1 g luminol was added to this 
solution. 1 ml of the luminol solution was mixed with 1 ml of 
the hydrogen peroxide solution. This mixture was transferred 
into the culture bottle ring on top of the chip. The chip was 
covered with a black box and the lights were switched off to 
eliminate ambient light. Finally, 0.5 ml of peroxidase 
conjugated antibody solution was added to the liquid on top of 
the chip and the liquid started glowing. The light output was 
measured with the SPAD array. The concentration of the 
peroxidase conjugated antibody was varied. The antibodies 
were obtained from Sigma- Aldrich (A9917). 1 ml of 4-
11 mg/ml concentration antibody was diluted in 200 ml of 
phosphate buffered saline. This stock solution (1:200) was 
used and further diluted in purified water for the experiments, 
up to 1:800. The concentration of the hydrogen peroxide 
solution was varied by diluting a 30% stock solution with 
purified water in the range of 0.15% to 0.3%. 
 
C. Refractive index sensing 
Monolithic integration of nanophotonic sensors with the 
CMOS detectors such as photodiode (PD) adds another 
functionality to our sensing platform. The monolithic 
integration of nanophotonic sensors with CMOS technology 
not only exploits the advantages offered by nanophotonic 
sensors such as label free sensing and high sensitivity but also 
makes the use of nanophotonic sensors practical by 
eliminating the requirement of external laboratory based 
equipment used for their readout such as optical spectrum 
analyser (OSA). One technique used for sensing by 
nanophotonic sensors is refractive index sensing where a 
change in the refractive index of the surrounding environment 
caused by introduction of an analyte or by bio-
functionalisation of sensor surface induces a shift in the 
resonant wavelength of the nanophotonic structures. In this 
work, by monolithically integrating nanophotonic structures 
with CMOS PD the wavelength shift is measured as a change 
in the output voltage of the PD. We used an array of gold 
nanodiscs as refractive index sensor due to its high sensitivity 
and ease of fabrication. This concept can be extended to a 
range of nanophotonic sensors having different designs and 
composed of different materials [10]. The schematic of the 
device is shown in Fig 7. 
The resonance response of the gold nanodiscs array was 
optimised using commercial finite element method (FEM). 
software (Comsol Multiphysics). The gold nanodisc array was 
then fabricated on top of CMOS chip by e-beam lithography 
followed by a lift-off process. Prior to fabricating gold  
 
Fig. 7.  Schematic of the gold nanodisc array monolithically integrated 
with CMOS PDs. 
 
 
Fig. 8.  Change in output voltage of the CMOS PDs with and without gold 
nanodiscs due to refractive index changes corresponding to different 
concentrations of glycerol. 
 
nanodiscs, a 500 nm thick layer of silica was deposited on top 
of CMOS chip to keep the resonance of the gold nanodiscs at 
lower wavelengths. A monochromator was used as an incident 
light source to match the wavelength of the incident light with 
the transmission dip of the gold nanodiscs but in principle a 
cheap light emitting diode can be used instead. The 
performance of the integrated system was investigated by 
changing the refractive index of the resonance wavelength 
which was measured directly as a change in the CMOS PD 
output voltage as shown in Fig 8.  A 10% change in glycerol 
concentration (refractive index change, Δn ≈ 0.011) causes a 
wavelength shift of 2-3 nm which translates to a 0.06 V 
change in the output voltage of the CMOS PD. These values 
correspond to the optical and electrical sensitivities of 275 
nm/RIU and 5.8 V/RIU respectively. While this work gives a 
proof of concept demonstration of working of the 
nanophotonic - CMOS electronic integrated sensing system by 
sensing changes in glycerol concentrations, future work will 
carry out more sensitive bio-assays by improving the 
sensitivity of the device. 
IV. CONCLUSION 
In this paper we described the use of two CMOS based 
detectors, namely PD and SPAD to interface with biology for 
performing colorimetric, chemiluminescence and refractive 
index sensing. The PD and SPAD array chip has been 
presented as a low cost and miniaturised version of a 
spectrophotometer, luminometer and conventional refractive 
index sensor. In this work, we demonstrated that PD, SPAD 
and nanophotonic sensor can be integrated onto a CMOS 
platform, leading to a possible integration of the three sensing 
techniques onto a single chip. This can be further integrated 
with existing microelectronics onto a single CMOS chip, 
paving the way for the development of point-of-care 
diagnostics for personalised healthcare. 
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